New acting director of Center for Medicare and Medicaid Innovation named

The Centers for Medicare & Medicaid Services disclosed this week that Richard Gilfillan, a former healthcare executive, has been tapped to be acting director of the new Center for Medicare and Medicaid Innovation (CMI).

CMI, a product of the Patient Protection and Affordable Care Act, will be expected to test innovative payment and service delivery models to reduce costs and improve quality. The law requires that the secretary of the Department of Health and Human Services create the CMI within CMS by Jan. 1, 2011.

Gilfillan is the former president and CEO of Geisinger Health Plan in Danville, PA. He also was executive vice president of insurance operations for Geisinger Health System, a large integrated heath system. Gilfillan joined CMS in August directing the agency's performance-based payment policy staff and implementing programs. He will work with CMS Administrator Donald Berwick in his new role. 


More in News

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

Judge dismisses claims of 'nationwide' Medicare fraud in ...

Long-term care pharmacy Omnicare will not face against charges that it engaged in "nationwide" Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the pharmacy still faces ...

Long-term care providers should follow hospitals in adopting EHRs, government says ...

Healthcare providers have already exceeded the government's 2013 adoption goals for electronic health records, the Department of Health and Human Services announced Wednesday.

Five-day COPD treatment quells flare-ups, reduces side effects, researchers find

Patients with chronic obstructive pulmonary disease flare-ups do better with a shorter round of prednisone, researchers have found.